Senge T - Search Results

1

Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.

Kurth K, Schroeder FH, Debruyne F, Senge T, Pavone-Macaluso M, de Pauw M, ten Kate F, Sylvester R. Kurth K, et al. Among authors: senge t. Prog Clin Biol Res. 1989;303:481-90. Prog Clin Biol Res. 1989. PMID: 2675005 Clinical Trial. No abstract available.

2

Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.

Kurth KH, Debruyne FJ, Senge T, Carpentier PJ, Riedl H, Sylvester R, de Pauw M. Kurth KH, et al. Among authors: senge t. Prog Clin Biol Res. 1985;185B:135-42. Prog Clin Biol Res. 1985. PMID: 3898138 Clinical Trial. No abstract available.

3

Clinical experience with cyproterone acetate in a randomised and in an open trial.

Tunn UW, Weiglein W, Saborowski J, Senge T. Tunn UW, et al. Among authors: senge t. Prog Clin Biol Res. 1987;243A:365-8. Prog Clin Biol Res. 1987. PMID: 2958860 Clinical Trial. No abstract available.

4

Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.

Schulze H, Kaldenhoff H, Senge T. Schulze H, et al. Among authors: senge t. Urol Int. 1988;43(4):193-7. doi: 10.1159/000281336. Urol Int. 1988. PMID: 2973169 Clinical Trial.

5

Quality of life of patients with renal cell carcinoma or prostate cancer after radical surgery.

Pannek J, Hallner D, Kugler J, Haupt G, Krüskemper GM, Senge T. Pannek J, et al. Among authors: senge t. Int Urol Nephrol. 1997;29(6):637-43. doi: 10.1007/BF02552179. Int Urol Nephrol. 1997. PMID: 9477360

6

Critical evaluation of treatment of staghorn calculi by percutaneous nephrolithotomy and extracorporeal shock wave lithotripsy.

Schulze H, Hertle L, Kutta A, Graff J, Senge T. Schulze H, et al. Among authors: senge t. J Urol. 1989 Apr;141(4):822-5. doi: 10.1016/s0022-5347(17)41020-2. J Urol. 1989. PMID: 2926872

7

Cyproterone acetate in the treatment of advanced prostatic cancer: retrospective analysis of liver toxicity in the long-term follow-up of 89 patients.

Hinkel A, Berges RR, Pannek J, Schulze H, Senge T. Hinkel A, et al. Among authors: senge t. Eur Urol. 1996;30(4):464-70. doi: 10.1159/000474216. Eur Urol. 1996. PMID: 8977068

8

Effects of cyproterone acetate on experimentally induced canine prostatic hyperplasia. A morphological and histochemical study.

Tunn U, Senge T, Schenck B, Neumann F. Tunn U, et al. Among authors: senge t. Urol Int. 1980;35(2):125-40. doi: 10.1159/000280312. Urol Int. 1980. PMID: 6154989

9

Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate.

Tunn U, Senge T, Schenck B, Neumann F. Tunn U, et al. Among authors: senge t. Acta Endocrinol (Copenh). 1979 Jun;91(2):373-84. doi: 10.1530/acta.0.0910373. Acta Endocrinol (Copenh). 1979. PMID: 88858

10

Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.

Tunn UW, Schüring B, Senge T, Neumann F, Schweikert HU, Rohr HP. Tunn UW, et al. Among authors: senge t. Invest Urol. 1981 Jan;18(4):289-92. Invest Urol. 1981. PMID: 6161104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters